These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29937938)
1. Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin. Ma Q; Feng Y; Deng K; Shao H; Sui T; Zhang X; Sun X; Jin L; Ma Z; Luo G J Cancer; 2018; 9(12):2183-2190. PubMed ID: 29937938 [TBL] [Abstract][Full Text] [Related]
2. The Inhibition of Serine/Threonine Protein Phosphatase Type 5 Mediates Cantharidin Toxicity to Control Sun H; Li Y; Li X; Zhang Y Insects; 2020 Oct; 11(10):. PubMed ID: 33050059 [TBL] [Abstract][Full Text] [Related]
3. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Liu Q; Sun H; Li X; Sheng H; Zhu L Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851 [TBL] [Abstract][Full Text] [Related]
4. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro. Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524 [TBL] [Abstract][Full Text] [Related]
5. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response. Yan J; Deng XL; Ma SQ; Hui Li Y; Gao YM; Shi GT; Wang HS BMC Complement Med Ther; 2023 May; 23(1):160. PubMed ID: 37202806 [TBL] [Abstract][Full Text] [Related]
6. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms. Ren J; Li G; Zhao W; Lin L; Ye T World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171 [TBL] [Abstract][Full Text] [Related]
8. Norcantharidin modulates development of dendritic cells and prolongs skin allograft survival. Hsieh CH; Liao HF; Kuo CD; Huang YC; Shueng PW; Hsu YP; Wang LY; Tsai TH; Chen YJ Transplantation; 2011 Oct; 92(8):848-57. PubMed ID: 21876479 [TBL] [Abstract][Full Text] [Related]
9. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells. Chen YJ; Chang WM; Liu YW; Lee CY; Jang YH; Kuo CD; Liao HF Chem Biol Interact; 2009 Oct; 181(3):440-6. PubMed ID: 19616522 [TBL] [Abstract][Full Text] [Related]
10. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma. Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217 [TBL] [Abstract][Full Text] [Related]
11. Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways. Ji BC; Hsiao YP; Tsai CH; Chang SJ; Hsu SC; Liu HC; Huang YP; Lien JC; Chung JG Anticancer Res; 2015 Feb; 35(2):729-38. PubMed ID: 25667452 [TBL] [Abstract][Full Text] [Related]
12. Medical uses of mylabris in ancient China and recent studies. Wang GS J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797 [TBL] [Abstract][Full Text] [Related]
13. Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling. Sun CY; Zhu Y; Li XF; Tang LP; Su ZQ; Wang XQ; Li CY; Yang HM; Zheng GJ; Feng B Oncotarget; 2017 Dec; 8(70):114945-114955. PubMed ID: 29383132 [TBL] [Abstract][Full Text] [Related]
14. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. Kok SH; Hong CY; Kuo MY; Lee CH; Lee JJ; Lou IU; Lee MS; Hsiao M; Lin SK Oral Oncol; 2003 Jan; 39(1):19-26. PubMed ID: 12457717 [TBL] [Abstract][Full Text] [Related]
15. Review targeted drug delivery systems for norcantharidin in cancer therapy. Zhai BT; Sun J; Shi YJ; Zhang XF; Zou JB; Cheng JX; Fan Y; Guo DY; Tian H J Nanobiotechnology; 2022 Dec; 20(1):509. PubMed ID: 36463199 [TBL] [Abstract][Full Text] [Related]
16. Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways. Zheng LC; Yang MD; Kuo CL; Lin CH; Fan MJ; Chou YC; Lu HF; Huang WW; Peng SF; Chung JG Anticancer Res; 2016 Nov; 36(11):6031-6042. PubMed ID: 27793930 [TBL] [Abstract][Full Text] [Related]
17. Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways. Hsia TC; Yu CC; Hsu SC; Tang NY; Lu HF; Huang YP; Wu SH; Lin JG; Chung JG Int J Oncol; 2014 Jul; 45(1):245-54. PubMed ID: 24818581 [TBL] [Abstract][Full Text] [Related]
18. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization. Hong KO; Ahn CH; Yang IH; Han JM; Shin JA; Cho SD; Hong SD Molecules; 2019 May; 24(10):. PubMed ID: 31109130 [TBL] [Abstract][Full Text] [Related]
19. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma. Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403 [TBL] [Abstract][Full Text] [Related]
20. Norcantharidin, derivative of cantharidin, for cancer stem cells. Hsieh CH; Chao KS; Liao HF; Chen YJ Evid Based Complement Alternat Med; 2013; 2013():838651. PubMed ID: 24073010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]